홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

1-Methyl-2-(tributylstannyl)-1H-imidazole → N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-2-yl)thieno[3,2-b]pyridin-7-yloxy)phenyl)-2-(4-fluorophenyl)-3-oxo-2,3-dihydropyridazine-4-carboxamide

HRID 1676409
인쇄

반응식

HRID 1676409 반응식
[F:1][C:2]1[CH:3]=[C:4]([NH:19][C:20]([C:22]2[C:23](=[O:35])[N:24]([C:28]3[CH:33]=[CH:32][C:31]([F:34])=[CH:30][CH:29]=3)[N:25]=[CH:26][CH:27]=2)=[O:21])[CH:5]=[CH:6][C:7]=1[O:8][C:9]1[CH:14]=[CH:13][N:12]=[C:11]2[CH:15]=[C:16](I)[S:17][C:10]=12.[CH3:36][N:37]1[CH:41]=[CH:40][N:39]=[C:38]1[Sn](CCCC)(CCCC)CCCC>C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1.C1(C)C=CC=CC=1>[F:1][C:2]1[CH:3]=[C:4]([NH:19][C:20]([C:22]2[C:23](=[O:35])[N:24]([C:28]3[CH:33]=[CH:32][C:31]([F:34])=[CH:30][CH:29]=3)[N:25]=[CH:26][CH:27]=2)=[O:21])[CH:5]=[CH:6][C:7]=1[O:8][C:9]1[CH:14]=[CH:13][N:12]=[C:11]2[CH:15]=[C:16]([C:38]3[N:37]([CH3:36])[CH:41]=[CH:40][N:39]=3)[S:17][C:10]=12
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 2

HCID 27632521-Methyl-2-(tributylstannyl)-1H-imidazoleHCID 67348506N-(3-fluoro-4-(2-iodothieno[3,2-b]pyridin-7-yloxy)phenyl)-2-(4-fluorophenyl)-3-oxo-2,3-dihydropyridazine-4-carboxamide

생성물 1

HCID 58949491N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-2-yl)thieno[3,2-b]pyridin-7-yloxy)phenyl)-2-(4-fluorophenyl)-3-oxo-2,3-dihydropyridazine-4-carboxamide수율 75.2%

시약·촉매·용매 2

HCID 178418397
HCID 178418397, 화합물
촉매
HCID 1140Toluene용매

반응 조건

온도
100 °C

실험 절차

A round-bottomed flask was charged with N-(3-fluoro-4-(2-iodothieno[3,2-b]pyridin-7-yloxy)phenyl)-2-(4-fluorophenyl)-3-oxo-2,3-dihydropyridazine-4-carboxamide (230 mg, 0.382 mmol), 1-methyl-2-(tributylstannyl)-1H-imidazole (850.3 mg, 2.29 mmol), tetrakis(triphenylphosphine)palladium (88.25 mg, 0.0764 mmol) and toluene (25 mL). The reaction mixture was stirred at 100° C. until LC-MS showed that the starting material had been consumed (4 hours). Then the reaction was cooled to room temperature and partitioned between EtOAc (100 mL) and H2O (100 mL). The phases were separated and the aqueous phase was re-extracted with EtOAc (3×100 mL). The combined organic layers were dried (Na2SO4), filtered and concentrated to yield a crude product. The crude product was purified by silica gel chromatography (DCM/7 M NH3 in MeOH from 50/1 to 10/1, v/v) to afford product (159.8 mg, 75.2%). LRMS (APCI pos): >99% purity, 254 nm, m/e 557 (M+1). 1H NMR (400 MHz, CDCl3) δ 11.82 (s, 1H), 8.50 (m, 1H), 8.41 (m, 1H), 8.22 (m, 1H), 7.98 (m, 1H), 7.46-7.42 (m, 4H), 7.40 (m, 2H), 7.24 (m, 2H), 6.98 (d, 1H), 6.54 (m, 1H), 3.84 (s, 3H).

후처리

  1. customhad been consumed (4 hours)
  2. temperatureThen the reaction was cooled to room temperature
  3. custompartitioned between EtOAc (100 mL) and H2O (100 mL)
  4. customThe phases were separated
  5. extractionthe aqueous phase was re-extracted with EtOAc (3×100 mL)
  6. dry with materialThe combined organic layers were dried (Na2SO4)
  7. filtrationfiltered
  8. concentrationconcentrated
  9. customto yield a crude product
  10. customThe crude product was purified by silica gel chromatography (DCM/7 M NH3 in MeOH from 50/1 to 10/1

출처 및 근거

ORD 기록
ord-93f47cf3e91244d6902676495af7bddf
출처 데이터셋
uspto-grants-2011_08
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08003662B2

반응 노트

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트